Hormonal composition based on a progestational agent and an oestrogen and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 1, 2012
Grant Date -
N/A
app pub date -
Oct 29, 1999
filing date -
Oct 25, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method of preventing estrogen deficiencies and osteoporosis in menopausal women by continuously orally administering without interruption to menopausal women in need thereof an amount of 0.3 to 3 mg of 17β-estradiol or esters thereof and 0.3 to 1.25 mg of nomegestrol or esters thereof in an amount sufficient to prevent said problems.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully